Children, Families, and the 2026 Revised Blood Guidance for Jehovah's Witnesses - An Update for Pediatric Hematology and ...

CAR-T therapy, which transformed the treatment of B-cell blood cancers, is now being tested as a way to reset the immune system in severe ...

Neil Kramer, MD, is a rheumatologist at Atlantic Health Overlook Medical Center, Physician Researcher, Atlantic Health ...

Breast Cancer Awareness Month has evolved far beyond a public-health campaign. Over four decades, patient advocacy, philanthropy, data collection, molecular science, and increasingly sophisticated ...

A Bullish Biotech Funding Market and a Higher Bar for Companies Seeking Capital - Importance of milestone-based development ...

Calvin Chao, MD, MBA, Vice President of Medical Science at Artera, is a medical executive with expertise spanning oncology, ...

Artificial intelligence (AI) is increasingly used in oncology to support tasks such as clinical-trial matching, evidence ...

What 195 Clinical Trials Reveal About the State of Artificial Intelligence in Oncology and Hematology in 2026.

Breast cancer prevention remains an important opportunity to move care earlier in the disease continuum, particularly by ...

Biotech leadership cannot stay static as a company moves from the benchtop to the clinic, writes Chris Ehrlich, CEO of CERo Therapeutics. Drawing on his experience backing and building companies from ...

Daiichi Sankyo and Merck & Co/MSD have withdrawn their U.S. application seeking accelerated approval of ifinatamab deruxtecan ...

Steven Quay M.D., Ph.D. has served as President and Chief Executive Officer since founding Atossa Therapeutics in 2009. A ...